Literature DB >> 34949787

Intravitreal injections as a leading cause of acute postoperative endophthalmitis-a regional survey in England.

Ariel Yuhan Ong1, Axelle Rigaudy2, Shafak Toufeeq3, Julian Robins4, Zaid Shalchi2, Mandeep Singh Bindra5, Peter Charbel Issa6,7.   

Abstract

BACKGROUND: To evaluate the characteristics, treatment patterns and outcomes of acute postoperative endophthalmitis.
METHODS: Patients presenting with acute postoperative endophthalmitis between January 2017 to December 2019 were identified from hospital records in this multicentre retrospective cohort study. Clinical records were reviewed for visual acuity (VA) at various timepoints, cause of endophthalmitis, microbiological results, treatments and complications.
RESULTS: Forty-six eyes of 46 patients were included. Intravitreal injections were the leading cause of acute postoperative endophthalmitis (n = 29; 63%), followed by cataract surgery (n = 8; 17%), vitreoretinal surgery (n = 7; 15%), and secondary intraocular lens insertion (n = 2, 4%). The absolute risk of endophthalmitis was 0.024% (1:4132) for intravitreal injections, 0.016% (1:6096) for cataract surgery, and 0.072% (1:1385) for vitreoretinal surgery. The majority of patients (n = 38; 83%) had better VA at 6 months compared to presentation, although fewer (n = 13; 28%) maintained similar or better VA compared to before the precipitating surgery. Twenty-four cases yielded positive culture results, of which staphylococcus epidermidis was the most commonly isolated organism. Microbiological yield was not associated with better final visual outcomes. Patients who underwent therapeutic vitrectomy (n = 15; 33%) had poorer VA at presentation, but subsequently achieved visual outcomes comparable to those who received medical treatment alone. There was no difference in time to presentation, visual outcome and retinal detachment rates among the different causative procedures.
CONCLUSION: Intravitreal injections were the most common cause of endophthalmitis in our region, primarily because of their higher frequency compared to other intraocular procedures. In this cohort, the primary procedure had no effect on presentation, management or visual outcomes.
© 2022. The Author(s).

Entities:  

Year:  2021        PMID: 34949787     DOI: 10.1038/s41433-021-01886-3

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

Review 1.  Endophthalmitis: state of the art.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Krishna Kishor; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2015-01-08

2.  Acute sterile endophthalmitis following intravitreal bevacizumab: case series.

Authors:  Axel Orozco-Hernández; Ximena Ortega-Larrocea; Gustavo Sánchez-Bermúdez; Gerardo García-Aguirre; Virgilio Morales Cantón; Raul Velez-Montoya
Journal:  Clin Ophthalmol       Date:  2014-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.